Literature DB >> 4093239

Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major.

G F Mitchell, E Handman, T W Spithill.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 4093239     DOI： 10.1016/0020-7519(85)90015-3

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN： 0020-7519            Impact factor:   3.981


× No keyword cloud information.
  10 in total

1.  Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice.

Authors:  D Frommel; B W Ogunkolade; I Vouldoukis; L Monjour
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Vaccination of humans against cutaneous leishmaniasis: cellular and humoral immune responses.

Authors:  E Nascimento; W Mayrink; C A da Costa; M S Michalick; M N Melo; G C Barros; M Dias; C M Antunes; M S Lima; D C Taboada
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8.

Authors:  M Colmenares; M Tiemeyer; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

4.  Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice.

Authors:  P J Murray; T W Spithill; E Handman
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Study of Leishmania major-infected macrophages by use of lipophosphoglycan-specific monoclonal antibodies.

Authors:  E Handman
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.

Authors:  E Handman; F M Symons; T M Baldwin; J M Curtis; J P Scheerlinck
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Hormonal modulation of sex differences in resistance to Leishmania major systemic infections.

Authors:  B A Mock; C A Nacy
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope.

Authors:  S Pingel; P Launois; D J Fowell; C W Turck; S Southwood; A Sette; N Glaichenhaus; J A Louis; R M Locksley
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.